Seroquel (quetiapine) is most likely to cause weight gain among these three medications.
Among Wellbutrin (bupropion), Seroquel (quetiapine), and buspirone, Seroquel carries by far the highest risk for clinically significant weight gain, while Wellbutrin actually promotes weight loss, and buspirone appears weight-neutral.
Weight Gain Risk Profile
Seroquel (Quetiapine) - HIGH RISK
Quetiapine is consistently associated with substantial weight gain across multiple high-quality guidelines and FDA labeling data 1, 2, 3:
- 23% of adults with schizophrenia gained ≥7% body weight (vs 6% placebo) 3
- 21% with bipolar mania gained ≥7% body weight (vs 7% placebo) 3
- 16% experienced weight gain >7% from baseline in randomized trials 2
- Mean weight gain of 1.1 kg in meta-analysis 4
- Dose-dependent effect: Higher doses increase both the magnitude of weight gain and risk of metabolically significant weight gain (≥7%) 5
The mechanism involves antagonism of histamine H1 receptors in the hypothalamus, anticholinergic effects, and serotonin 5-HT2C receptor antagonism 2. Quetiapine ranks among olanzapine, clozapine, and risperidone as the antipsychotics most consistently associated with weight gain 1.
Wellbutrin (Bupropion) - PROMOTES WEIGHT LOSS
Bupropion is the only antidepressant that consistently causes weight loss 1, 2:
- Mean weight loss of 1.3 kg in systematic reviews 2, 4
- Works by suppressing appetite and reducing food cravings through norepinephrine and dopamine reuptake inhibition 1
- FDA-approved for chronic weight management in combination with naltrexone (Contrave) 1
- Consistently demonstrated weight-reducing effects across multiple clinical trials 6, 7, 8
Buspirone - WEIGHT NEUTRAL
Buspirone, an anxiolytic acting on serotonin 5-HT1A receptors, has no significant association with weight change in the available evidence. It is not mentioned in any of the comprehensive pharmacotherapy guidelines addressing weight-altering medications 1, 2, 1, 2.
Clinical Implications
If weight gain is a concern:
- Avoid Seroquel - it carries substantial metabolic risk including weight gain, dyslipidemia, and increased diabetes risk
- Consider Wellbutrin if treating depression or as adjunct therapy - it actively promotes weight loss
- Buspirone is safe from a weight perspective for anxiety treatment
Common pitfall: Low-dose quetiapine (off-label for sleep/anxiety) still carries metabolic risk. While the dose-dependent relationship exists, even low doses can cause clinically significant weight gain 5. The harm should not be dismissed simply because the dose is lower than typical antipsychotic dosing.
Monitoring for Seroquel: If quetiapine must be used, implement regular weight monitoring and assess for metabolic syndrome components (lipids, glucose, blood pressure) given the 8-23% risk of ≥7% weight gain depending on indication 3.